These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3879247)

  • 41. Bacterial findings in middle ear effusion in children.
    Qvarnberg Y; Kantola O; Valtonen H; Vuori E; Salo J; Toivanen M
    Otolaryngol Head Neck Surg; 1990 Feb; 102(2):118-21. PubMed ID: 2113235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does the presence of pneumococcal DNA in middle-ear fluid indicate pneumococcal etiology in acute otitis media?
    Palmu AA; Saukkoriipi PA; Lahdenkari MI; Kuisma LK; Makela PH; Kilpi TM; Leinonen M
    J Infect Dis; 2004 Mar; 189(5):775-84. PubMed ID: 14976593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics.
    Leibovitz E; Raiz S; Piglansky L; Greenberg D; Yagupsky P; Fliss DM; Leiberman A; Dagan R
    Pediatr Infect Dis J; 1998 Jun; 17(6):463-9. PubMed ID: 9655535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nasopharyngeal bacteriology and secretory otitis media in young children.
    Sørensen CH; Andersen LP; Tos M; Thomsen J; Holm-Jensen S
    Acta Otolaryngol; 1988; 105(1-2):126-31. PubMed ID: 3257598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent epidemiology of Streptococcus pneumoniae in nasopharynxes of Korean children with acute otitis media.
    Han SB; Kim JH; Kang JH; Ma SH; Kim CS; Kim KH; Kim HM; Choi YY
    J Infect Chemother; 2017 Mar; 23(3):136-141. PubMed ID: 28024738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of pneumococcal polysaccharide vaccine (Prevnar) on middle ear fluid in children undergoing tympanostomy tube insertion.
    Caspary H; Welch JC; Lawson L; Darrow D; Buescher S; Shahab S; Derkay CS
    Laryngoscope; 2004 Jun; 114(6):975-80. PubMed ID: 15179198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    Cilveti R; Olmo M; Pérez-Jove J; Picazo JJ; Arimany JL; Mora E; Pérez-Porcuna TM; Aguilar I; Alonso A; Molina F; Del Amo M; Mendez C;
    PLoS One; 2017; 12(2):e0170316. PubMed ID: 28146590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology.
    Zhao AS; Boyle S; Butrymowicz A; Engle RD; Roberts JM; Mouzakes J
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):499-503. PubMed ID: 24461461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possibilities of preventing otitis media by vaccination.
    Mäkelä PH; Karma P; Sipilä M; Pukander J; Leinonen M
    Scand J Infect Dis Suppl; 1983; 39():34-8. PubMed ID: 6359378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
    Simell B; Korkeila M; Pursiainen H; Kilpi TM; Käyhty H
    J Infect Dis; 2001 Mar; 183(6):887-96. PubMed ID: 11237805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute excerbation.
    Tachibana F; Shimada T; Hori Y; Wada Y; Ishitani Y; Koike Y
    Auris Nasus Larynx; 1996; 23():20-5. PubMed ID: 8809319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of bacterial pathogens in otitis media with effusion.
    Post JC; Preston RA; Aul JJ; Larkins-Pettigrew M; Rydquist-White J; Anderson KW; Wadowsky RM; Reagan DR; Walker ES; Kingsley LA; Magit AE; Ehrlich GD
    JAMA; 1995 May 24-31; 273(20):1598-604. PubMed ID: 7745773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?
    Rapola S; Kilpi T; Lahdenkari M; Takala AK; Mäkelä PH; Käyhty H
    J Infect Dis; 2001 Sep; 184(5):577-81. PubMed ID: 11494164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
    Soriano F; Parra A; Cenjor C; Nieto E; García-Calvo G; Giménez MJ; Aguilar L; Ponte C
    J Infect Dis; 2000 Feb; 181(2):646-52. PubMed ID: 10669350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pneumococcal polysaccharide capsular antigens in chronic secretory otitis media.
    Palva T; Lehtinen T; Virtanen H
    Int J Pediatr Otorhinolaryngol; 1983 Nov; 6(2):145-9. PubMed ID: 6363320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media.
    Mäkelä PH; Leinonen M; Pukander J; Karma P
    Rev Infect Dis; 1981; 3 Suppl():S124-32. PubMed ID: 6974386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution.
    Dagan R; Leibovitz E; Greenberg D; Bakaletz L; Givon-Lavi N
    J Infect Dis; 2013 Oct; 208(7):1152-60. PubMed ID: 23842949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction.
    Angoulvant F; Cohen R; Doit C; Elbez A; Werner A; Béchet S; Bonacorsi S; Varon E; Levy C
    BMC Infect Dis; 2015 Jun; 15():236. PubMed ID: 26093673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Ubukata K; Morozumi M; Sakuma M; Takata M; Mokuno E; Tajima T; Iwata S;
    Pediatr Infect Dis J; 2018 Jun; 37(6):598-604. PubMed ID: 29474258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.